Imaging protocols for renal multiparametric MRI and MR urography: results of a consensus conference from the French Society of Genitourinary Imaging

Autor: Isabelle Boulay, Marie-France Bellin, S. Brunelle, Ingrid Millet, Xavier Matillon, Jean Tourniaire, Nicolas Grenier, Olivier Rouvière, Laurence Rocher, Raphaële Renard-Penna, Thomas Sanzalone, Olivier Hélénon, Jean-François Lapray, David Eiss, Arnaud Lefevre, Jean-Michel Ménager, François Cornelis, Sébastien Ronze, Catherine Roy, N. Girouin, Marc André
Přispěvatelé: Hôpital Edouard Herriot [CHU - HCL], Hospices Civils de Lyon (HCL), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon, Service de Radiologie [CHU Tenon], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Département de radiologie [Institut Paoli Calmettes], Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Nouvel Hôpital Civil de Strasbourg, Hôpital Européen [Fondation Ambroise Paré - Marseille], AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), Imagerie par Résonance Magnétique Médicale et Multi-Modalités (IR4M), Université Paris-Sud - Paris 11 (UP11)-Hôpital Bicêtre-Centre National de la Recherche Scientifique (CNRS), Centre hospitalier Saint-Joseph [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service de Radiologie et imagerie médicale [CHU Necker], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Necker - Enfants Malades [AP-HP], Université Paris Descartes - Faculté de Médecine (UPD5 Médecine), Université Paris Descartes - Paris 5 (UPD5), Norimagerie Caluire, CHU Bordeaux [Bordeaux], Imagerie Médicale Créqui, Centre d'Imagerie Tourville, Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Université de Lyon-Université de Lyon-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Centre d'Imagerie des Gratte-Ciel, Hôpital Lapeyronie [Montpellier] (CHU), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Imagerie médicale Val d'Ouest Charcot (IMVOC), Centre hospitalier de Valence, Clinique Rhône Durance, Service de Radiologie [CHU Pitié-Salpétrière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre National de la Recherche Scientifique (CNRS)-Hôpital Bicêtre-Université Paris-Sud - Paris 11 (UP11), CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)
Rok vydání: 2019
Předmět:
Male
Consensus Development Conferences as Topic
[SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology
030218 nuclear medicine & medical imaging
0302 clinical medicine
Transitional cell carcinoma
MESH: Urinary Tract
Urinary Tract
Societies
Medical
Neuroradiology
Urinary bladder
medicine.diagnostic_test
Ultrasound
Interventional radiology
Urography
General Medicine
3. Good health
medicine.anatomical_structure
030220 oncology & carcinogenesis
[SDV.IB]Life Sciences [q-bio]/Bioengineering
Female
Radiology
France
medicine.medical_specialty
Consensus
Urology
MESH: Societies
Medical
[SDV.CAN]Life Sciences [q-bio]/Cancer
Guidelines
03 medical and health sciences
MESH: Urography
Magnetic resonance imaging
medicine
Humans
Radiology
Nuclear Medicine and imaging
MESH: Consensus
Multiparametric Magnetic Resonance Imaging
Hematuria
MESH: Multiparametric Magnetic Resonance Imaging
MESH: Humans
business.industry
MESH: Consensus Development Conferences as Topic
MESH: Urology
MESH: Male
MESH: France
Contrast medium
business
Kidney neoplasms
MESH: Female
Pyelogram
Zdroj: European Radiology
European Radiology, Springer Verlag, 2020, 30 (4), pp.2103-2114. ⟨10.1007/s00330-019-06530-z⟩
ISSN: 1432-1084
0938-7994
DOI: 10.1007/s00330-019-06530-z⟩
Popis: To develop technical guidelines for magnetic resonance imaging aimed at characterising renal masses (multiparametric magnetic resonance imaging, mpMRI) and at imaging the bladder and upper urinary tract (magnetic resonance urography, MRU). The French Society of Genitourinary Imaging organised a Delphi consensus conference with a two-round Delphi survey followed by a face-to-face meeting. Two separate questionnaires were issued for renal mpMRI and for MRU. Consensus was strictly defined using a priori criteria. Forty-two expert uroradiologists completed both survey rounds with no attrition between the rounds. Fifty-six of 84 (67%) statements of the mpMRI questionnaire and 44/71 (62%) statements of the MRU questionnaire reached final consensus. For mpMRI, there was consensus that no injection of furosemide was needed and that the imaging protocol should include T2-weighted imaging, dual chemical shift imaging, diffusion-weighted imaging (use of multiple b-values; maximal b-value, 1000 s/mm2) and fat-saturated single-bolus multiphase (unenhanced, corticomedullary, nephrographic) contrast-enhanced imaging; late imaging (more than 10 min after injection) was judged optional. For MRU, the patients should void their bladder before the examination. The protocol must include T2-weighted imaging, anatomical fast T1/T2-weighted imaging, diffusion-weighted imaging (use of multiple b-values; maximal b-value, 1000 s/mm2) and fat-saturated single-bolus multiphase (unenhanced, corticomedullary, nephrographic, excretory) contrast-enhanced imaging. An intravenous injection of furosemide is mandatory before the injection of contrast medium. Heavily T2-weighted cholangiopancreatography-like imaging was judged optional. This expert-based consensus conference provides recommendations to standardise magnetic resonance imaging of kidneys, ureter and bladder. • Multiparametric magnetic resonance imaging (mpMRI) aims at characterising renal masses; magnetic resonance urography (MRU) aims at imaging the urinary bladder and the collecting systems. • For mpMRI, no injection of furosemide is needed. • For MRU, an intravenous injection of furosemide is mandatory before the injection of contrast medium; heavily T2-weighted cholangiopancreatography-like imaging is optional.
Databáze: OpenAIRE
Externí odkaz: